In Vitro and In Vivo Antibacterial Evaluation of Cadazolid, a New Antibiotic for Treatment of Clostridium difficile Infections

Clostridium difficile is a leading cause of health care-associated diarrhea with significant morbidity and mortality, and new options for the treatment of C. difficile-associated diarrhea (CDAD) are needed. Cadazolid is a new oxazolidinone-type antibiotic that is currently in clinical development fo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Locher, Hans H., Seiler, Peter, Chen, Xinhua, Schroeder, Susanne, Pfaff, Philippe, Enderlin, Michel, Klenk, Axel, Fournier, Elvire, Hubschwerlen, Christian, Ritz, Daniel, Kelly, Ciaran P., Keck, Wolfgang
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2014
Matèries:
Pharmacology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3910819/
https://ncbi.nlm.nih.gov/pubmed/24277020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01830-13
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars